Titre
Tramadol and Cycling: Is It the End of a "Painful" Relationship? An Insight From 60,802 Doping-Control Samples From 2012 to 2020.
Type
article
Institution
UNIL/CHUV/Unisanté + institutions partenaires
Auteur(s)
Zandonai, T.
Auteure/Auteur
Peiró, A.M.
Auteure/Auteur
Covelli, C.
Auteure/Auteur
de la Torre, X.
Auteure/Auteur
Botré, F.
Auteure/Auteur
Liens vers les personnes
Liens vers les unités
ISSN
1555-0273
Statut éditorial
Publié
Date de publication
2023-01-01
Volume
18
Numéro
1
Première page
95
Dernière page/numéro d’article
98
Peer-reviewed
Oui
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: epublish
Publication Status: epublish
Résumé
To assess the prevalence of tramadol use among athletes from 2012 to 2020.
All urine samples were collected from national and international in-competition doping-control tests that took place in Italy between 2012 and 2020. The analysis of the samples was performed by gas chromatography coupled with mass spectrometry with electronic ionization and acquisition in selected ion monitoring. The cutoff tramadol concentration was >50 ng/mL.
Of the 60,802 in-competition urine samples we analyzed, 1.2% (n = 759) showed tramadol intake, with 84.2% (n = 637) of these coming from cyclists and 15.8% (n = 122) from other sports. In cycling, a strong and significant negative correlation was found (r = -.738; P = .003), showing a decrease of tramadol use compared with the other sports.
The decrease in tramadol prevalence in cycling in the last years may be due to (1) the deterrent action of antidoping regulations and (2) the fact that tramadol may not have any actual ergogenic effect on performance.
All urine samples were collected from national and international in-competition doping-control tests that took place in Italy between 2012 and 2020. The analysis of the samples was performed by gas chromatography coupled with mass spectrometry with electronic ionization and acquisition in selected ion monitoring. The cutoff tramadol concentration was >50 ng/mL.
Of the 60,802 in-competition urine samples we analyzed, 1.2% (n = 759) showed tramadol intake, with 84.2% (n = 637) of these coming from cyclists and 15.8% (n = 122) from other sports. In cycling, a strong and significant negative correlation was found (r = -.738; P = .003), showing a decrease of tramadol use compared with the other sports.
The decrease in tramadol prevalence in cycling in the last years may be due to (1) the deterrent action of antidoping regulations and (2) the fact that tramadol may not have any actual ergogenic effect on performance.
PID Serval
serval:BIB_76C42F8C855B
PMID
Date de création
2022-12-12T10:11:02.135Z
Date de création dans IRIS
2025-05-21T02:07:30Z